GlaxoSmithKline PLC (NYSE:GSK) has a 1 Year Target Estimate of $48.25. The stock traded with the volume of 5.65 Million in the last trading session. GlaxoSmithKline PLC opened at $38.15 and closed by showing a decrease of -1.25%. The Bid price in the last session was $37.81 x 100 and the Ask price was $37.99 x 200. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).
GlaxoSmithKline PLC has the Market Capitalization of 94.11 Billion. The Stock has its 52-week High of $45.58 and 52-Week Low of $37.65 and it touched its 52-week high on Aug 2, 2016 and 52-Week Low on Nov 23, 2016.
GlaxoSmithKline PLC reported its last Earnings on Oct 26 where the company reported Actual EPS of $0.85/Share whereas, the Analyst Estimated EPS was $0.74/share. The difference between Actual EPS and Estimated EPS was $0.11/share. This represented an Earnings Surprise of 14.9%. The company will report its next earnings on Feb 1 – Feb 6 (Est.).
2 number of analysts also provided their insight on GlaxoSmithKline PLC, where the Average Price Target for the stock is $48.25. They also projected Low Price Target as $47.5 while High Price Target is set at $49.
A number of analysts rated the stock as well: 2 analysts believe that the stock is a STRONG BUY while 0 reported it as Buy.2 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.
GlaxoSmithKline PLC annual Divided is 2.09 while it’s Dividend Yield is 5.52%. The stock has its Price to Earnings (P/E) ratio of 253.62 and Forward Price to Earnings ratio of 13.75. The company has its Price to Sales (P/S) ratio of 2.78 where Price to Book (P/B) ratio of 539.86, Price to Cash Per share (P/C) of 15.73 and Price to Free Cash Flow (P/FCF) has a value of 0.
The company has its Return on Assets (ROA) of 0.5 Percent. Return on Equity (ROE) stands at 13.9% and Return on Investment (ROI) displays a value of 41.4%.
The stock is currently trading at Distance from 20-Day simple moving Average of -2.65% whereas, Distance from 50-Day Simple moving average is -6.78 Percent and Distance from 200-Day Simple Moving Average of -7.95 percent.
A look at performance overview of GlaxoSmithKline PLC depicts that Performance (Week) is -0.66 percent while Performance Month is -4.44%. Quarterly performance shows a value of -12.02% and Half Year Performance value stands at -8.82%. Yearly performance of the stock has the value of -1.21 percent. GlaxoSmithKline PLC has its YTD performance of 0.19 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).
The latest Upgrades/Downgrades was done by Research firm Investec on 20-Oct-16 who Initiated the stock to Buy. Other firms have also Upgraded/Downgraded the stock. On 23-Sep-16, Piper Jaffray took an action “Initiated” to Overweight. On 14-Jul-16, the stock was Upgrade to Buy by Jefferies.